Professional Documents
Culture Documents
REVIEW
Correspondence
Karen B. Eden, PhD,
Department of Medical
Informatics and Clinical
Epidemiology, Oregon
Health and Science
University, 3181 SW Sam
Jackson Park Rd, Portland,
OR 97229.
edenk@ohsu.edu
ABSTRACT
Keywords
VBAC
trial of labor
pregnancy
predictors
cesarean
evidence review
Data Extraction and Synthesis: The search yielded 3,134 abstracts: 69 full-text papers on TOL and vaginal birth
after cesarean (VBAC) rates and 10 on predictors of TOL. The TOL rate in U.S. studies was 58% (95% CI [52, 65])
compared with 64% (95% CI [59, 70]) in non U.S. studies. The TOL rate in the U.S. was 62% (95% CI [57, 66]) for
studies completed prior to 1996 and dropped to 44% (95% CI [34, 53]) in studies launched after 1996, p = .016. In U.S.
studies, 74% (95% CI [72, 76]) of women who had a TOL delivered vaginally. Women who had a prior vaginal birth or
delivered at a large teaching hospital were more likely to be offered a TOL.
Objective: To evaluate evidence on trial of labor (TOL) and vaginal delivery rates in women with a prior cesarean and
to understand the characteristics of women offered a trial of labor.
Data Sources: MEDLINE, DARE, and Cochrane databases were searched for articles evaluating mode of delivery for
women with a prior cesarean delivery published between 1980 and September 2009.
Study Selection: Studies were included if they involved human participants, were in English, conducted in the United
States or in developed countries, and if they were rated fair or good base on U.S. Preventive Services Task Force
(USPSTF) criteria.
Conclusions: Although the TOL rate has dropped since 1996, the rate of vaginal delivery after a TOL has remained
constant. Efforts to increase rates of TOL will depend on patients understanding the risks and benefits of both options.
Maternity providers are well positioned to provide key education and counseling when patients are not informed of their
options.
(Continued)
http://jognn.awhonn.org
rior to 1996, in the United States, the number of women having a vaginal birth after cesarean (VBAC) reached an all-time high of 28%
(Menacker, Declercq, & Macdorman, 2006). However, with the release of information on uterine rupture in 1996 (McMahon, Luther, Bowes, & Olshan,
1996), the number of women undergoing a trial of
labor (TOL) began to steadily decline. In 1999, the
American College of Obstetricians and Gynecologists (ACOG; 1999) recommended that hospitals
offering VBAC should have a surgical team immediately available throughout labor. Some hospitals
unable to provide an immediate surgical response
and concerned about liability during labor prohibited the practice of VBAC, which left some women
with no option for a TOL (Scott, 2010; Shorten,
2010). In one study, the authors reported that
prior to the 1999 ACOG guideline, 24% of eligible women in California hospitals had a TOL, and
immediately following the release, 13.5% of eligible women made the attempt, p < .001 (Zweifler
C 2012 AWHONN, the Association of Womens Health, Obstetric and Neonatal Nurses
583
REVIEW
Methods
Data Sources
584
Study Selection
Full-text studies were included if they explicitly reported on eligibility for TOL and if they provided
data for computing the TOL rate or vaginal delivery
rate after a TOL at the study sites. We were particularly interested in studies that provided information on influencing factors and predictors of TOL.
Non-U.S. studies were included if the study was
conducted in a developed country because the
available technology and medical response were
thought to be similar to the United States and were
published in English (The World Factbook, 2008).
Two investigators reviewed each full-text article for
inclusion or exclusion. We excluded studies that
included women without a prior cesarean delivery, nulliparous patients, 10 participants or fewer,
breech delivery, exclusive focus on preterm delivery or low birth weight, multiple gestation, or
abortions.
Task Force (USPSTF) and the National Health Service Centre for Reviews and Dissemination (Harris
et al., 2001; Healthy Inclusion, 2001). Two reviewers independently reviewed the studies. When
reviewers disagreed, a final rating was reached
through discussion and consensus of the whole
team. Studies that were rated as poor quality were
excluded from analyses. Parameters that were
particularly important for TOL and VBAC rates
were clear definition of eligibility for TOL, comparable groups, reliable and valid outcomes, unbiased assessment of measures, follow-up long
enough for outcome to occur, acceptable level
of attrition (40%), and adjustment for potential
confounders (Guise, Denman, et al., 2010; Guise,
Eden, et al., 2010). For studies reporting on the
factors influencing or predicting TOL, clear definition of all factors was critical (Guise, Eden, et al.).
Data from included papers were extracted by one
researcher into evidence tables and verified by a
second.
Analysis
Meta-analyses were conducted using a random
effects model (DerSimonian & Laird, 1986) to summarize TOL and vaginal delivery rates. Statistical
heterogeneity was assessed by using the standard chi-squared test and the I2 statistic (the
proportion of variation in study estimates due to
heterogeneity rather than sampling error) (Higgins, Thompson, Deeks, & Altman, 2003; Higgins, Thompson, Higgins, & Thompson, 2002).
To explore heterogeneity, we performed subgroup
analyses and meta-regression (Sutton, Abrams,
Jones, Sheldon, & Song, 2000; Thompson &
Sharp, 1999) to evaluate whether the summary
estimates differed by study-level characteristics,
including U.S. versus non-U.S. population, gestational age of the population (term vs. any gestational age), and year of data collection of the
study.
Results
As shown in Figure 1, of 3,134 citations identified
in searches, 963 full-text papers were reviewed
and 69 studies that contained adequate data to
compute the TOL and/or vaginal delivery rate, and
10 studies on predictors of TOL met the inclusion
and quality standards. We included 19 studies of
good quality and 50 studies of fair quality that provided evidence on TOL and VBAC rates (Table 1).
The majority (7 of 10) of the studies providing
evidence on individual predictors were of good
quality (Cameron, Roberts, & Peat 2004; Chang,
Stamilio, & Macones, 2008; DeFranco et al., 2007;
http://jognn.awhonn.org
REVIEW
Figure 1. Search and Selection of Literature for TOL rate and Vaginal Delivery Rate after TOL.
TOL = trial of labor; VBAC = vaginal birth after cesarean.
a
Many studies are included in more than one topic area. Adapted with permission from Guise, J. M., Eden, K., Emeis, C., Denman,
M., Marshall, N., Fu, R., . . . McDonagh, M. (2010). Vaginal birth after cesarean: New insights. Evidence Report/Technology
Assessment No. 191 (AHRQ publication no. 10-E001). Rockville, MD: Agency for Healthcare Research and Quality. Also adapted
with permission from Wolters Kluwer. from Eden, K.B., (2010). New insights on vaginal birth after cesarean, can it be predicted?
TOL Rate
Thirty-five studies consisting of 10 prospective
and 25 retrospective cohort studies provided data
on TOL rates (Table 1). These studies included
661,765 women and provided a combined TOL
rate of 61% (95% CI [57, 65]). However, the rates
of TOL significantly varied across the studies ranging from 28% to 82% (p < .0001) with an I2
for between-heterogeneity of greater than 99%
(Figure 2). Results from metaregression indicated
that TOL rates differed significantly by gestational
age and year of study (p < .05) but not by study
design (retrospective vs. prospective) or country.
As shown in Figure 2, the overall TOL rate in studies conducted in the United States was 58% (95%
585
REVIEW
Quality
U.S. or
Cohort
Evidence
Evidence for
Non-U.S.
Design
for TOL
Vaginal Delivery
after TOLa
586
Bais, 2001
Fair
Non
Prospective
Cameron, 2004
Good
Non
Retrospective
Caughey, 1999
Fair
US
Retrospective
Costantine, 2009
Good
US
Retrospective
De Franco, 2007
Good
US
Retrospective
Delaney, 2003
Fair
Non
Retrospective
DiMaio, 2002
Fair
US
Retrospective
Dinsmoor, 2004
Fair
US
Retrospective
Durnwald, 2004a
Fair
US
Retrospective
Durnwald, 2004b
Fair
US
Retrospective
El-Sayed, 2007
Fair
US
Retrospective
X (Term)
Elkousy, 2003
Fair
US
Retrospective
X (Term)
Fisler, 2003
Fair
US
Retrospective
Flamm, 1987
Fair
US
Retrospective
Flamm, 1994
Good
US
Prospective
Gonen, 2006
Fair
Non
Retrospective
Goodall, 2005
Fair
US
Retrospective
Gregory, 1999
Good
US
Retrospective
Gregory, 2008
Fair
US
Retrospective
X (Term)
Gyamfi, 2004
Good
US
Retrospective
X (Term)
Hammoud, 2004
Fair
Non
Retrospective
Hashima, 2007
Fair
US
Retrospective
X (Term)
X
X (Term)
X
X
X
X (Term)
X
X
X (Term)
X
Hendler, 2004
Good
Non
Prospective
Hibbard, 2006
Good
US
Prospective
Hollard, 2006
Good
US
Retrospective
Hook, 1997
Good
US
Prospective
Horenstein, 1984
Fair
US
Retrospective
Horenstein, 1985
Fair
US
Retrospective
Hoskins, 1997
Fair
US
Retrospective
Huang, 2002
Fair
US
Retrospective
X (Term)
Hueston, 1994
Fair
US
Retrospective
Jakobi, 1993
Good
Non
Prospective
Johnson, 1991
Fair
US
Retrospective
Juhasz, 2005
Fair
US
Retrospective
Kugler, 2008
Fair
Non
Retrospective
Landon, 2006
Fair
US
Prospective
Learman, 1996
Good
US
Retrospective
X
X
X (Term)
X
X (Term)
http://jognn.awhonn.org
REVIEW
Table 1: Continued
Study
Quality
U.S. or
Cohort
Evidence
Evidence for
Non-U.S.
Design
for TOL
Vaginal Delivery
after TOLa
Lieberman, 2004
Fair
US
Prospective
Locatelli, 2004
Good
Non
Retrospective
Loebel, 2004
Fair
US
Retrospective
X (Term)
Macones, 2005
Fair
US
Retrospective
McMahon, 1996
Good
Non
Retrospective
McNally, 1999
Fair
Non
Retrospective
Nguyen, 1992
Fair
US
Retrospective
Obara, 1998
Fair
Non
Retrospective
Ouzounian, 1996
Fair
US
Retrospective
Pang, 2009
Good
Non
Retrospective
Pathadey, 2005
Fair
Non
Retrospective
Phelan, 1987
Fair
US
Prospective
Pickhardt, 1992
Fair
US
Retrospective
X
X
X (Term)
Raynor, 1993
Fair
US
Retrospective
Rozenberg, 1996
Good
Non
Prospective
Rozenberg, 1999
Fair
Non
Prospective
Sakala, 1990
Fair
US
Retrospective
Selo-Ojeme, 2008
Fair
Non
Retrospective
X (Term)
Smith, 2002
Good
Non
Retrospective
X (Term)
Smith, 2005
Good
Non
Retrospective
X (Term)
Socol, 1999
Fair
US
Retrospective
Spaans, 2002
Fair
Non
Retrospective
Stovall, 1987
Fair
US
Prospective
Strong, 1996
Fair
Non
Prospective
Troyer, 1992
Fair
US
Retrospective
X (Term)
Fair
Non
Prospective
Vinueza, 2000
Fair
US
Retrospective
Weinstein, 1996
Good
Non
Retrospective
Wen, 2004
Fair
Non
Retrospective
Yetman, 1989
Fair
US
Retrospective
Yogev, 2004
Fair
Non
Retrospective
Zelop, 2001
Fair
US
Retrospective
X (Term)
Lieberman, 2003; Flamm, Goings, Liu, & WoldeTsadik, 1994; Gregory, Korst, Cane, Platt, & Kahn,
1999; Hook, Kiwi, Amini, Fanaroff, & Hack, 1997;
Hueston & Rudy, 1994; Phelan, Clark, Diaz, &
587
REVIEW
Figure 2. Trial of labor in studies conducted in the United States and outside the United States. Adapted with permission from Guise, J. M., Eden, K., Emeis,
C., Denman, M., Marshall, N., Fu, R., . . . McDonagh, M. (2010). Vaginal birth after cesarean: New insights. Evidence Report/Technology Assessment No. 191
(AHRQ publication no. 10-E001). Rockville, MD: Agency for Healthcare Research and Quality.
588
http://jognn.awhonn.org
REVIEW
Vaginal birth after cesarean: New insights. Evidence Report/Technology Assessment No. 191 (AHRQ publication no. 10-E001).
Rockville, MD: Agency for Healthcare Research and Quality.
Figure 4. TOL and vaginal delivery rates with TOL over time.
589
REVIEW
Figure 5. Rate of vaginal delivery with TOL in studies conducted in the United States.
Reprinted with permission from Guise, J. M., Eden, K., Emeis, C., Denman, M., Marshall, N., Fu, R., . . . McDonagh, M. (2010).
Vaginal birth after cesarean: New insights. Evidence Report/Technology Assessment No. 191 (AHRQ publication no. 10-E001).
Rockville, MD: Agency for Healthcare Research and Quality.
Using only the subset of the U.S. studies that provided data to compute the TOL and vaginal delivery rates with TOL, the rates were ordered by
year the data collection was launched (ranged
between 19822002) and plotted together on the
same chart, Figure 4. With the exception of one
retrospective study that focused on costs of de-
590
http://jognn.awhonn.org
REVIEW
Figure 6. Rate of vaginal delivery with TOL in studies conducted outside the United States.
Reprinted with permission from Guise, J. M., Eden, K., Emeis, C., Denman, M., Marshall, N., Fu, R., . . . McDonagh, M. (2010).
Vaginal birth after cesarean: New insights. Evidence Report/Technology Assessment No. 191 (AHRQ publication no. 10-E001).
Rockville, MD: Agency for Healthcare Research and Quality.
591
REVIEW
592
http://jognn.awhonn.org
REVIEW
Discussion
Vaginal delivery rates for women who had a TOL
have remained constant over the same time period. Since 1996, the number of women who had
a TOL at sites still offering TOLs fell to less than
one half of those eligible. Among women who had
a TOL, 74% delivered vaginally. The vaginal delivery rate with TOL in this updated evidence report is
consistent with the previously reported rate (76%)
in the 2003 evidence report on VBAC (Guise et al.,
2003). The newer evidence suggests that many
women who would have delivered vaginally had
elective cesarean deliveries either by own choice
or because of barriers in the health system. It is
important to note that the TOL and vaginal delivery rates with TOL summarized in this report were
obtained from sites that still provided TOLs. Our
reported vaginal delivery rates with TOL will exceed reported national VBAC rates that include
sites that limit (or prohibit) TOLs.
With newly issued concluding consensus statements, rates of TOL may again increase for stud-
ies launched after 2010. The 2010 Consensus Development Panel on VBAC urged that barriers to
TOL be removed to again give a woman an opportunity to make an informed choice with her
provider: We recommend that hospitals, maternity care providers, healthcare and professional
liability insurers, consumers, and policymakers
collaborate on the development of integrated services that could mitigate or even eliminate current
barriers to TOL (U.S. Department of Health and
Human Services, 2010, p. 3).
Although some barriers are obvious to the patient,
for example, the hospital will not allow TOLs, efforts are needed to address less obvious barriers
(to the patient), such as liability to the provider.
In a survey of ACOG fellows, 41% of the 639
Characteristic
Adjusted Odds
95% CI
1.00
Referent
0.46
0.29, 0.74
0.57
0.38, 0.85
0.38
0.25, 0.56
1.00
Referent
1.22
1.09, 1.37
0.90
0.81, 0.99
0.66
0.58, 0.74
Private
0.45
0.41, 0.50
Hospital Level
Cameron, 2004
Level 13 (Rural)
McMahon, 1996
Tertiary care
1.00
Referent
Regional hospital
0.50
0.50, 0.60
Community hospital
0.40
0.30, 0.50
1.00
Referent
No program
0.88
0.82, 0.95
Teaching Status
DeFranco, 2007
593
REVIEW
Nursing Implications
National guidelines on VBAC from the Royal College of Obstetricians and Gynaecologists in the
United Kingdom and Womens Hospital Australasia (Australia) emphasize the importance of offering women information so that they can discuss the childbirth options (Foureur, Ryan, Nicholl,
& Homer, 2010). Although U.S. providers report
knowing the risks and benefits of VBAC and RCD
(Coleman et al., 2005), it is not clear that many
patients are aware of such risks and benefits or
are prepared to advocate for their desired mode of
delivery. Perinatal nurses, nurse practitioners, and
certified nurse midwives are well positioned to assess womens knowledge about delivery options
and their associated risks and benefits. When
knowledge is lacking, they can provide education
and counseling to address this need.
The importance of informing patients also
emerged in the vision statement from Childbirth
Connections Transforming Maternity Care, a collaboration of 100 national leaders representing obstetrics, nurse-midwifery, maternity nursing, family
medicine, health policy, health economics, quality,
Characteristic
Adjusted odds
95% CI
Ratio or Relative
Risk for VBAC
Number of Previous Vaginal Deliveries
Cameron, 2004, Retrospective Cohort
1 Prior VD
1.51
1.35, 1.68
2 Prior VDs
2.35
1.92, 2.86
3 Prior VDs
2.94
2.23, 3.88
1 Prior VD
3.20
Not reported
2 Prior VDs
4.00
Not reported
History of VD
6.67
2.70, 16.67
Note. CI = confidence interval; VD = vaginal delivery; VBAC = vaginal birth after cesarean.
Reprinted with permission from Guise, J. M., Eden, K., Emeis, C., Denman, M., Marshall, N., Fu, R., . . . McDonagh, M. (2010). Vaginal
birth after cesarean: New insights. Evidence Report/Technology Assessment No. 191 (AHRQ publication no. 10-E001). Rockville, MD:
Agency for Healthcare Research and Quality.
594
http://jognn.awhonn.org
REVIEW
Acknowledgment
Based on a systematic evidence review conducted for and presented to the National Institutes
of Health Consensus Development Conference
on Vaginal Birth After Cesarean: New Insights.
Funded by the Agency for Healthcare Research
and Quality (AHRQ), Contract No. HHSA 2902007-10057-I, Task Order No. 4 for the Office of
Medical Applications of Research at the National
Institutes of Health. The findings and conclusions
in this document are those of the authors, who are
responsible for its content, and do not necessarily
represent the views of AHRQ. No statement in this
report should be construed as an official position
of AHRQ or of the U.S. Department of Health and
Human Services.
REFERENCES
gynecologists. American College of Obstetricians and Gynecologists. (1999). International Journal of Gynaecology & Obstetrics, 66(2), 197204.
American College of Obstetricians and Gynecologists. (2010). ACOG
practice bulletin no. 115: Vaginal birth after previous ce-
595
REVIEW
El-Sayed, Y. Y., Watkins, M. M., Fix, M., Druzin, M. L., Pullen, K. M., &
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D.,
Preventive Services Task Force: A review of the process. American Journal of Preventive Medicine, 20(3, Suppl 1), 2135.
Elkousy, M. A., Sammel, M., Stevens, E., Peipert, J. F., & Macones,
Healthy Inclusion. (2001). Undertaking systematic reviews of research on effectiveness: CRDs guidance for those carry-
Fisler, R. E., Cohen, A., Ringer, S. A., & Lieberman, E. (2003). Neona-
healthy-inclusion.org.uk/
C., & Hersh, E. (1987). Oxytocin during labor after previous ce-
sarean section: Results of a multicenter study. Obstetrics & Gynecology, 70(5), 709712.
Flamm, B. L., Goings, J. R., Liu, Y., & Wolde-Tsadik, G. (1994). Elec-
932.
Foureur, M., Ryan, C. L., Nicholl, M., & Homer, C. (2010). Inconsistent
Hollard, A. L., Wing, D. A., Chung, J. H., Rumney, P. J., Saul, L., Na-
as a risk factor for failed trial of labor in patients with previous ce-
192(5), 14231426.
Gregory, K. D., Korst, L. M., Cane, P., Platt, L. D., & Kahn, K. (1999).
Hook, B., Kiwi, R., Amini, S. B., Fanaroff, A., & Hack, M. (1997). Neonatal
Guise, J. M., Denman, M., Emeis, C., Marshall, N., Walker, M., Fu, R., . . .
115(6), 12671278.
Guise, J. M., Eden, K., Emeis, C., Denman, M., Marshall, N., Fu, R.,
591593.
. . . McDonagh, M. (2010). Vaginal birth after cesarean: New insights. Evidence report/technology assessment No. 191 (AHRQ
Jakobi, P., Weissman, A., Peretz, B. A., & Hocherman, I. (1993). Evaluation of prognostic factors for vaginal delivery after cesarean
Gyamfi, C., Juhasz, G., Gyamfi, P., & Stone, J. L. (2004). Increased suc-
Johnson, C., Oriol, N., & Flood, K. (1991). Trial of labor: A study of 110
Hammoud, A., Hendler, I., Gauthier, R. J., Berman, S., Sansregret, A.,
& Bujold, E. (2004). The effect of gestational age on trial of labor after cesarean section. Journal of Maternal-Fetal & Neonatal
sion 214215.
Juhasz, G., Gyamfi, C., Gyamfi, P., Tocce, K., & Stone, J. L. (2005). Ef-
Harper, L. M., Cahill, A. G., Stamilio, D. M., Odibo, A. O., Peipert, J. F.,
596
Kabir, A. A., Pridjian, G., Steinmann, W. C., Herrera, E. A., & Khan,
276.e271276.
http://jognn.awhonn.org
REVIEW
Kugler, E., Shoham-Vardi, I., Burstien, E., Mazor, M., & Hershkovitz,
Phelan, J. P., Clark, S. L., Diaz, F., & Paul, R. H. (1987). Vaginal birth
157(6), 15101515.
Landon, M. B., Spong, C. Y., Thom, E., Hauth, J. C., Bloom, S. L., Varner,
Rozenberg, P., Goffinet, F., Phillippe, H. J., & Nisand, I. (1996). Ultra-
933942.
Livingston, G., & Cohn, D. V. (2010). U.S. birth rate decline linked
Rozenberg, P., Goffinet, F., Philippe, H. J., & Nisand, I. (1999). Thickness
2010/10/753-birth-rates-recession.pdf
Locatelli, A., Regalia, A. L., Ghidini, A., Ciriello, E., Biffi, A., & Pezzullo,
Sakala, E. P., Kaye, S., Murray, R. D., & Munson, L. J. (1990). Oxytocin
Loebel, G., Zelop, C. M., Egan, J. F. X., & Wax, J. (2004). Maternal
Selo-Ojeme, D., Abulhassan, N., Mandal, R., Tirlapur, S., & Selo-Ojeme,
102(2), 156159.
Shorten, A. (2010). Bridging the gap between mothers and medicine:
New Insights from the NIH Consensus Conference on VBAC.
Birth, 37(3), 181183.
Siegal, R. (Narrator). (2010, August 25). Birth rates drop amid falter-
1662.
J., Kirmeyer, S., & Osterman, M. J. (2010). Births: Final data for
Nguyen, T. V., Dinh, T. V., Suresh, M. S., Kinch, R. A., & Anderson, G.
Obara, H., Minakami, H., Koike, T., Takamizawa, S., Matsubara, S.,
713717.
Pang, M. W., Law, L. W., Leung, T. Y., Lai, P. Y., & La, T. K. (2009).
Sutton, A. J., Abrams, K. R., Jones, D. R., Sheldon, T. A., & Song,
597
REVIEW
U.S. Department of Health and Human Services. National Institutes of Health. (2010). NIH consensus development confer-
2010/images/vbac/vbac_statement.pdf
van Gelderen, C. J., England, M. J., Naylor, G. A., & Katzeff, T. C.
Yetman, T. J., & Nolan, T. E. (1989). Vaginal birth after cesarean section:
Yogev, Y., Ben-Haroush, A., Lahav, E., Horowitz, E., Hod, M., & Kaplan,
Vinueza, C. A., Chauhan, S. P., Barker, L., Hendrix, N. W., & Scardo, J.
336.
598
Weinstein, D., Benshushan, A., Tanos, V., Zilberstein, R., & Rojansky, N.
Zelop, C. M., Shipp, T. D., Cohen, A., Repke, J. T., & Lieberman,
198.
393.
Wen, S. W., Rusen, I. D., Walker, M., Liston, R., Kramer, M. S., Bas-
Zweifler, J., Garza, A., Hughes, S., Stanich, M. A., Hierholzer, A., & Lau,
228234.
http://jognn.awhonn.org